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A complete hydatidiform mole (CHM) is androgenetic in origin and
characterized by enhanced trophoblastic proliferation and the
absence of fetal tissue. In 15 to 20% of cases, CHMs are followed
by malignant gestational trophoblastic neoplasms including cho-
riocarcinoma. Aberrant genomic imprinting may be responsible for
trophoblast hypertrophy in CHMs, but the detailed mechanisms
are still elusive, partly due to the lack of suitable animal or in vitro
models. We recently developed a culture system of human tropho-
blast stem (TS) cells. In this study, we apply this system to CHMs for a
better understanding of their molecular pathology. CHM-derived TS
cells, designated as TSmole cells, are morphologically similar to bipa-
rental TS (TSbip) cells and express TS-specific markers such as GATA3,
KRT7, and TFAP2C. Interestingly, TSmole cells have a growth advan-
tage over TSbip cells only after they reach confluence. We found that
p57KIP2, a maternally expressed gene encoding a cyclin-dependent
kinase inhibitor, is strongly induced by increased cell density in
TSbip cells, but not in TSmole cells. Knockout and overexpression stud-
ies suggest that loss of p57KIP2 expression would be the major cause
of the reduced sensitivity to contact inhibition in CHMs. Our findings
shed light on the molecular mechanism underlying the pathogenesis
of CHMs and could have broad implications in tumorigenesis beyond
CHMs because silencing of p57KIP2 is frequently observed in a variety
of human tumors.
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Acomplete hydatidiform mole (CHM) is a gestational tro-phoblastic disease characterized by enhanced trophoblast
proliferation, swollen villi, and the absence of embryonic compo-
nents (1). Whereas the core mesenchyme of normal villi is sur-
rounded by a single layer of cytotrophoblast (CT) cells, CHM villi
contain multiple layers (2). Although CHMs are benign in most
cases, 15 to 20% of them are followed by malignant gestational
trophoblastic neoplasms, including invasive mole and choriocarci-
noma (3). CHMs develop from androgenetic conceptuses (4, 5) and
can be placed into 2 classes: monospermic and dispermic. The
majority of CHMs are monospermic and arise from fertilization
of an anucleate egg with a haploid sperm, followed by endo-
redupliction. Dispermic CHMs account for 4 to 15% of CHMs and
develop through fertilization of an anucleate egg with 2 sperm (6).
Whereas most autosomal genes are expressed from both pa-
rental alleles, a small subset of genes, known as imprinted genes,
are exclusively expressed from 1 parental allele (7). To date, more
than 100 imprinted genes have been identified in humans (8), and
many of them are expressed in the placenta (9). Aberrant genomic
imprinting may be responsible for the pathogenesis of CHMs.
However, it remains uncertain which imprinted gene(s) are in-
volved in the overgrowth of trophoblast cells in CHMs, partly due
to the lack of suitable animal or in vitro models. For example,
androgenetic mouse embryos exhibit severe growth retardation
and early lethality. The extraembryonic tissues develop relatively
well in these embryos but do not give rise to malignant tropho-
blastic neoplasms (10, 11). Moreover, some immortalized cell lines
have been established from CHMs by transducing oncogenes such
as human telomerase reverse transcriptase (12, 13), but forced
expression of oncogenes affects cell proliferation and can mask
the phenotype of CHMs.
Recently, we have succeeded in establishing human trophoblast
stem (TS) cells from cytotrophoblast (CT) cells isolated from first-
trimester placentas (14). Here, we apply this culture system to
CHMs and reveal that CHM-derived TS cells exhibit resistance to
contact inhibition, which may be accounted for by loss of p57KIP2
(CDKN1C) expression. These findings are fundamental to un-
derstanding the pathogenesis of CHMs and normal placental
development.
Results
Establishment and Molecular Characterization of TS Cells from CHMs.
We isolated CT cells from 5 CHM samples and established TS
cell lines (Fig. 1A and SI Appendix, Table S1). These cells,
designated as TSmole cells, were morphologically similar to
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biparental TS (TSbip) cells (Fig. 1B) and expressed trophoblast
markers such as TFAP2C, GATA3, and KRT7 (Fig. 1C). We
performed copy number variation (CNV) analysis of 3 TSmole cell
lines with the Japonica array, which is a SNP array optimized for
the Japanese population, and revealed genome-wide loss of het-
erogeneity (Fig. 1D). Thus, these 3 lines may be derived from
monospermic fertilization.
To further characterize TSmole cells, we performed RNA se-
quencing (RNA-seq) and whole genome bisulfite sequencing
(WGBS) on 3 TSmole cell lines. RNA-seq and WGBS data
for TSbip cells were obtained from our previous study and used
for comparison (14). TSmole and TSbip cells had very similar
transcriptome and methylome profiles, and the expression levels
of differentiation markers were low in these cells (SI Appendix,
Fig. S1 and Dataset S1). However, expression and DNA meth-
ylation of imprinted genes were disturbed in TSmole cells (Fig. 2A
and Dataset S2). We focused on 10 maternally expressed and 15
paternally expressed genes that maintain allele-specific expres-
sion in primary CT cells (15). Among the maternally expressed
genes, H19 and p57KIP2 were expressed at the lowest level in
TSmole cells compared to TSbip cells. Consistently, the paternally
methylated H19 DMR was hypermethylated and the maternally
methylated KvDMR1 was unmethylated in TSmole cells (Fig. 2 C
and D). KvDMR1 overlaps with the promoter of the paternally
expressed noncoding RNA KCNQ1OT1, which may be involved
in the repression of neighboring genes such as KCNQ1 and
p57KIP2 (16). However, several maternally expressed genes, such
as NAA60 and GRB10, showed comparable expression levels in
TSmole and TSbip cells (Fig. 2A). This was unlikely to be due to an
artifact of in vitro culture because the expression levels of NAA60
and GRB10 were also similar between primary CT cells isolated
from CHMs and normal placentas (Fig. 2B).
We also revealed that paternally expressed genes with high
expression levels in TSbip cells tended to show increased expres-
sion in TSmole cells (Fig. 2A). However, several genes, includ-
ing PEG3 and AIM1, did not show increased expression in
TSmole cells, which was inconsistent with the methylation pat-
terns of their regulatory elements (Fig. 2 E and F). Intriguingly,
increased expression of paternally expressed genes was less
apparent in primary CT cells isolated from CHMs (Fig. 2B).
Although we analyzed only 2 CT samples from CHMs and more
samples are needed to draw a firm conclusion, these data suggest
that there may be a compensatory mechanism whereby the ex-
pression levels of some imprinted genes are normalized in
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Fig. 1. Establishment of TSmole cells. (A) Representative CHM image. Swollen villi are visible. (B) Phase-contrast images of TSbip and TSmole cells. (C) Immu-
nostaining of TFAP2C, GATA3, and KRT7. Nuclei were counterstained with Hoechst 33258. (D) CNV analysis of TSbip and TSmole cells. B allele frequency (BAF)
and log2 copy number ratio (log2 ratio) are shown. Genome-wide loss of heterogeneity was observed in TS
mole cell lines without copy number changes. (Scale
bars: B, 200 μm; C, 100 μm.)



































Resistance to Contact Inhibition in TSmole Cells. Since CHMs are
characterized by trophoblast hypertrophy, we analyzed the pro-
liferation rate of TSmole cells. However, TSmole cells had a pro-
liferation rate comparable to TSbip cells under optimal conditions
where the cells were passaged before they reached confluence
(Fig. 3A). It has been recognized that although the core mesen-
chyme of normal villi is surrounded by a single layer of CT cells,
CHM villi contain multiple layers (2). This implies that tropho-
blast cells of CHMs might be resistant to contact inhibition of
proliferation. Consistent with this, we found that TSmole cells had a
significant growth advantage over TSbip cells after they reached
confluence (Fig. 3B).
Cell cycle analysis using flow cytometry revealed that
Bromodeoxyuridine (BrdU)-labeled S phase cells dramatically
decreased when TSbip cells were cultured at a high cell density
(Fig. 3C). Both G1 and G2 arrest were responsible for the re-
duction of S phase cells (SI Appendix, Fig. S2 A and B). Cell
density-dependent reduction of S phase cells was also observed
in TSmole cells, but to a much lesser extent than TSbip cells (Fig. 3
C and D), reinforcing the idea that TSmole cells have reduced
sensitivity to contact inhibition. The cell cycle analysis also
revealed that some TSmole cell lines contained substantial pro-
portions of cells >4n (Fig. 3E and SI Appendix, Table S1). As
cells >8n were negligible, these lines were thought to contain
mitotically active tetraploid cells (SI Appendix, Fig. S2C). The
proportion of cells >4n was marginally reduced by increased cell
density (SI Appendix, Fig. S2D). We found a significant relationship
(r = −0.72, P = 0.02) between the proportion of cells >4n and cell
doubling time (Fig. 3F), but the sample size was small, and further
work is required to establish the negative correlation.
Identification of p57KIP2 as a Regulator of Contact Inhibition in TS
Cells. We were next interested in why TSmole cells had reduced
sensitivity to contact inhibition. Abnormal expression of imprinted
gene(s) is considered to be involved in this phenotype. We focused
on p57KIP2 because this gene functions as a cyclin-dependent
kinase inhibitor and was expressed at a very low level in
TSmole cells (Fig. 2A). Moreover, previous studies have revealed
that p57KIP2 expression is absent or very low in CT cells of CHMs
and the majority of choriocarcinoma samples associated with CHMs
(17, 18). Although few TSbip cells expressed p57KIP2 when they were
cultured at a low density, p57KIP2 was strongly induced when cul-
tured at a high density (Fig. 4 A–C). In contrast, p57KIP2-positive
cells were almost absent in TSmole cells regardless of cell den-
sity. We also observed a ∼30-fold induction of p57KIP2 mRNA
in TSbip cells cultured at a high density (Fig. 4D). Among
the 14 imprinted genes labeled in Fig. 2A, p57KIP2 was most
strongly induced by high cell density (Fig. 4D and SI Appendix, Fig.
S3). These data suggest that transcriptional regulation may be an
important determinant of the abundance of p57KIP2 in TSbip cells,
although we do not exclude the possibility of posttranscriptional
regulation.
To determine whether loss of p57KIP2 expression is responsible
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Fig. 2. RNA-seq and WGBS of TSmole cells. (A) Expression levels of imprinted genes in TSbip and TSmole cells. Three lines were analyzed for each cell type, and
mean expression levels are shown. Maternally and paternally expressed genes are represented in red and blue, respectively. Genes with >10 FPKM in TSbip
cells are labeled with their gene names. (B) Expression levels of imprinted genes in CT cells isolated from biparental placentas (CTbip) and CHMs (CTmole). Three
CTbip and two CTmole samples were analyzed, and mean expression levels are shown. Genes are labeled as in A. (C) DNA methylation patterns at the H19 DMR.
The H19 DMR is shown in yellow, and its methylation levels are indicated on the right. (D) DNA methylation patterns at KvDMR1 (yellow). (E) DNA meth-
ylation patterns at the PEG3 DMR (yellow). (F) DNA methylation patterns at the AIM1 DMR (yellow). See also Datasets S1 and S2.




























we utilized the doxycycline (Dox)-inducible Tet-on system (Fig. 5A).
Three TSmole cell lines with Dox-inducible p57KIP2 were cul-
tured at a high density, and their cell cycle was analyzed by
flow cytometry. The fluorescence intensity of p57KIP2 induced by
Dox was comparable to that observed in TSbip cells cultured at a high
density (SI Appendix, Fig. S4A). We found that p57KIP2 induction
significantly reduced the proportion of cells in S phase (Fig. 5 B
and C), which supports the idea that loss of p57KIP2 confers
resistance to contact inhibition in TSmole cells. To reinforce this
idea, we generated p57KIP2 knockout TS cells using the
CRISPR-Cas9 system. We transfected 1 TSbip cells line with
lentivirus-expressing Cas9 and gRNA and isolated 14 clones.
Two of these were p57KIP2-positive and the others were p57KIP2-
negative (Fig. 5D). One of the p57KIP2-positive clones was wild
type, and the other was heterozygous, implying that the paternal
allele was mutated (SI Appendix, Fig. S4 B andC). These 2 lines were
used as controls. We randomly selected 4 of the p57KIP2-negative
clones, which were all confirmed to be homozygous knockouts (SI
Appendix, Fig. S4C), and analyzed their proliferation. We found that
at a high cell density, the proportion of S phase cells was much
higher in p57KIP2-negative clones than in p57KIP2-positive clones
(Fig. 5 E and F). Consistently, p57KIP2-negative clones had higher
proliferative activity than p57KIP2-positive clones after reaching
confluence (Fig. 5G). These data reveal that, similar to TSmole cells,
p57KIP2 knockout TS cells have reduced sensitivity to contact in-
hibition. However, the proportion of cells >4n was comparable be-
tween p57KIP2-negative and p57KIP2-positive clones, suggesting that
loss of p57KIP2 may not be the cause of the genome amplification in
TSmole cells (Fig. 5H).
Discussion
Previous studies on mouse androgenetic cell lines have revealed
important roles of genomic imprinting in cell proliferation.
Similar to TSmole cells, androgenetic mouse embryonic fibro-
blasts (MEFs) have increased saturation density (19). In-
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Fig. 3. Reduced sensitivity to contact inhibition in TSmole cells. (A) Cumulative growth curves of TSbip and TSmole cells. Three TSbip and three TSmole cell lines
were seeded at a density of 5,000 cells/cm2. The cells were passaged when they reached ∼80% confluence and counted every 4 d. (B) Growth curves of TSbip
and TSmole cells. Three TSbip and five TSmole cell lines were analyzed. Cells were seeded at a density of 10,000 cells/cm2 and maintained for 6 d without
passaging. TSmole cells had significantly higher cell numbers than TSbip at day 6 (P < 0.01; Student’s t test). Data are presented as means + SDs (n = 3). (C) Cell
cycle analysis of TSbip and TSmole cells. Cells were seeded at a density of 5,000 (Low) or 100,000 cells/cm2 (High). After 2 d of culture, the cells were labeled with
BrdU for an hour and analyzed by flow cytometry. Nuclei were stained with PI. The proportions of cells in S phase are indicated. (D) Summary of the cell cycle
analysis in C. Three TSbip and five TSmole cell lines were analyzed. Statistical analysis was performed by the Bonferroni/Dunn test. **P < 0.01; NS, not sig-
nificant. (E) DNA ploidy analysis of TSbip and TSmole cells. DNA ploidy was measured using cells that were seeded at a high density (100,000 cells/cm2) and
cultured for 2 d. (F) Relationship between DNA ploidy and cell doubling time. Three TSbip and five TSmole cell lines were analyzed and are shown in blue and
red, respectively. A negative correlation was observed between cell doubling time during the exponential phase and the proportion of cells >4n, which was
calculated from the data in E. Pearson’s r was −0.72 (P = 0.02) when all samples were considered and −0.95 (P = 0.05) when only TSmole samples were
considered.



































enhanced proliferation of androgenetic MEFs, because knockout
of p57KIP2 has no effect on the proliferation of biparental MEFs.
Alternatively, increased Igf2 and loss of Igf2r, which is a maternally
expressed imprinted gene and encodes a decoy receptor for IGF2,
seem to stimulate the proliferation of androgenetic MEFs. It is
also known that androgenetic mouse TS cells exhibit enhanced
proliferation activity. Whereas biparental mouse TS cells require
Fgf4 for their proliferation, androgenetic mouse TS cells continue
to proliferate for up to 6 d in the absence of Fgf4 (20). Again,
p57KIP2 is unlikely to be the major cause of the Fgf4-independent
proliferation because p57KIP2 is expressed at similar levels in bi-
parental and androgenetic mouse TS cells. Gab1, which is pater-
nally expressed in the mouse placenta but not imprinted in the
human placenta (21), is proposed to be a candidate gene for the
Fgf4-independent proliferation (22). These findings suggest that
although androgenesis is associated with enhanced cell pro-
liferation, the underlying mechanisms may vary among tissues
and species.
p57KIP2 is a putative tumor suppressor gene and most highly
expressed in the placenta in both humans and mice (23, 24).
Consistent with the function and expression pattern, p57KIP2-
deficient mice exhibit placentomegaly (25, 26) and loss of
p57KIP2 function is associated with Beckwith–Wiedemann syn-
drome (BWS) in humans, which is characterized by overgrowth
of multiple organs including the placenta (16, 27). However, it
has been unclear how the expression and function of p57KIP2 are
regulated in the placenta. We showed that p57KIP2 is strongly
induced by increased cell density in TSbip cells. This observation
is consistent with the expression pattern of p57KIP2 in the pla-
centa. The core mesenchyme of placental villi is surrounded by a
single layer of proliferative CT cells that sporadically express
p57KIP2 (28). At the tip of villi, CT cells form stratified aggre-
gates known as cell columns, where they exit cell cycle and start
to differentiate into extravillous cytotrophoblast (EVT) cells
(29). p57KIP2 is strongly expressed in most CT cells that exit cell











































































Fig. 4. Cell density-dependent induction of p57KIP2 in TSbip cells but not in TSmole cells. (A) Immunostaining images of p57KIP2 in TSbip and TSmole cells. Cells
were seeded at a density of 5,000 (Low) or 100,000 cells/cm2 (High). After 2 d of culture, cells were analyzed. Nuclei were stained with Hoechst 33258. (Scale
bar: 100 μm.) (B) Flow cytometry analysis of p57KIP2 in TSbip and TSmole cells. Cells cultured as shown in A were analyzed. Nuclei were stained with PI. The
proportions of p57KIP2-positive cells are indicated. (C) Summary of flow cytometry analysis of p57KIP2 in B. Three TSbip and three TSmole cell lines were analyzed.
(D) Expression levels of p57KIP2 in TSbip and TSmole cells. Three TSbip and three TSmole cell lines were cultured as shown in A and analyzed by quantitative real-
time PCR. The data were normalized to GAPDH and B2M.




























density might be a trigger of p57KIP2 in vivo too. Our data strongly
suggest that p57KIP2 is involved in cell cycle arrest in TS cells, but
further studies are needed to determine whether p57KIP2 regulates
permanent cell cycle exit and EVT differentiation.
Loss of p57KIP2 is observed in both CHMs and most BWS pa-
tients (16). Since malignant gestational trophoblastic neoplasms
are not clinical characteristics of BWS, loss of p57KIP2 alone
cannot account for the high risk of malignancy in CHMs. Poly-
ploidy could be another risk factor. We found that some
TSmole cell lines contain high proportions of cells >4n, and the
experiments presented suggest that loss of function of p57KIP2 is
not responsible for that phenotype. Polyploid cells are also
observed in a subset of CHMs in vivo, and such CHMs are
suspected to be prone to malignant gestational trophoblastic
neoplasms (30, 31). Consistently, most invasive moles and cho-
riocarcinomas exhibit genome amplification (32, 33). However, the
frequency of CHMs containing polyploid cells is highly variable
among studies, ranging from 2 to 30%, which may be due to in-
consistent diagnostic criteria (34, 35). More studies using stan-
dardized criteria are needed to determine whether polyploidy is
associated with malignant transformation in CHMs. Also, the
mechanism underlying the polyploidization remains unknown.
In conclusion, we established and characterized TSmole cells,
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Fig. 5. Identification of p57KIP2 as a regulator of contact inhibition in TS cells. (A) Overexpression of p57KIP2 in TSmole cells. TSmole cells with Dox-inducible
p57KIP2 were seeded at a high density (100,000 cells/cm2) and cultured for 24 h. Then, the cells were treated with 20 ng/mL Dox for 24 h, and p57KIP2
expression was analyzed by flow cytometry. Nuclei were stained with PI. The proportions of p57KIP2-positive cells are indicated. Similar results were
obtained with 3 independent TSmole cell lines. (B) p57KIP2-induced reduction of S phase cells. Cells were cultured as shown in A and analyzed by flow
cytometry after BrdU treatment. Nuclei were stained with PI. The proportions of cells in S phase are indicated. (C ) Summary of the cell cycle analysis in B.
Three TSbip and three TSmole cell lines were analyzed. Statistical analysis was performed by Student’s t test. **P < 0.01. (D) Confirmation of loss of p57KIP2
expression in p57KIP2 knockout clones. Cells were seeded at a high density (100,000 cells/cm2). After 2 d of culture, p57KIP2 expression was analyzed by
flow cytometry. The proportions of p57KIP2-positive cells are indicated. Representative p57KIP2-positive (+) and p57KIP2-negative (−) clones are shown. (E )
Cell cycle analysis of p57KIP2(+) and p57KIP2(−) clones. Cells were seeded at a low (5,000 cells/cm2) or high density (100,000 cells/cm2). After 2 d of culture,
the cells were labeled with BrdU and analyzed by flow cytometry. The proportions of cells in S phase are indicated. (F ) Summary of the cell cycle analysis
in E. Two p57KIP2(+) and four p57KIP2(−) clones were analyzed. Statistical analysis was performed by the Bonferroni/Dunn test. **P < 0.01; *P < 0.05. (G)
Reduced sensitivity to contact inhibition in p57KIP2(−) clones. Cells were seeded at a density of 10,000 cells/cm2 as in Fig. 3B and maintained for 5
d without passaging. TSmole cells had significantly higher cell numbers than TSbip cells (P < 0.05; Student’s t test). Data are presented as means + SDs (n =
3). (H) Proportions of cells >4n in p57KIP2(+) and p57KIP2(−) clones. Two p57KIP2(+) and four p57KIP2(−) clones were analyzed. Statistical analysis was
performed by Student’s t test. NS, not significant.



































contact inhibition. p57KIP2 is required for normal development
of multiple organs, and loss of methylation of KvDMR1, which
results in loss of p57KIP2 expression, is common in human adult
tumors (36). Therefore, our findings could have broad implica-
tions in embryogenesis and tumorigenesis beyond CHMs.
Materials and Methods
Sample Collection. Placental samples were collected from patients after
written informed consent was obtained. Experienced pathologists confirmed
the diagnosis of CHMs. This study was approved by the Ethics Committee
of Tohoku University Graduate School of Medicine (Research license
2017-1-349).
Culture of TS Cells. TSmole cells were established as described previously (14).
Briefly, CT cells were isolated from CHM tissues and cultured on plates
coated with 5–10 μg/mL Col IV (Corning) using TS medium (DMEM/F12
[Wako] supplemented with 0.1 mM 2-mercaptoethanol [Wako], 0.2% FBS
[Thermo Fisher Scientific], 0.5% Penicillin-Streptomycin [Thermo Fisher Sci-
entific], 0.3% BSA [Wako], 1% ITS-X supplement [Wako], 1.5 μg/mL
L-ascorbic acid [Wako], 50 ng/mL EGF [Wako], 2 μM CHIR99021 [Wako],
0.5 μM A83-01 [Wako], 1 μM SB431542 [Wako], 0.8 mM VPA [Wako], and
5 μM Y27632 [Wako]). TSbip #1, #2, and #3 were established in our previous
study (14) and correspond to TSCT #1, #2, and #3, respectively. TSbip #4 was
established in this study and used only for CNV analysis. Unless otherwise
noted, we used TSmole and TSbip cells passaged 10–20 times for the analysis.
Overexpression of p57KIP2. Vectors for Dox-inducible p57KIP2 expression were
constructed as follows. The Tet-On 3G transactivator of the pTetOne vector
(Takara) was PCR-amplified and cloned into the multicloning site of the
CS-CA-MCS plasmid (kindly provided by H. Miyoshi, RIKEN BioResource
Center, Ibaraki, Japan) using the In-Fusion HD Cloning kit (Takara). The
resulting vector was designated as pCS-CA-Tet3G. The CAG promoter of CS-
CA-MCS was replaced with the TRE3Gs promoter of pTetOne. The resulting
vector was designated as pCS-3G. The coding region of p57KIP2 was PCR-
amplified from cDNA prepared from TSbip cells and cloned into pCS-3G to
generate pCS-3G-p57KIP2. Sequences of the primers used for vector con-
struction are shown in Dataset S3.
To generate lentivirus expressing Tet-On 3G, pCS-CA-Tet3G was cotrans-
fected with pCMV-VSV-G-RSV-Rev and pCAG-HIVgp (kindly provided by
H. Miyoshi, RIKEN BioResource Center) into 293T cells using Lipofectamine
LTX (Thermo Fisher Scientific). Tenmicomolar Forskolin (Wako)was added after
24 h of transfection. The supernatant was collected after 3 d of transfection,
concentrated with Lenti-X Concentrator (Takara), and stored at −80 °C.
Lentivirus-expressing p57KIP2 was also generated using pCS-3G-p57KIP2.
TSmole cells harboring Dox-inducible p57KIP2 were generated by adding
lentivirus-expressing Tet-On 3G and p57KIP2 to the culture medium.
p57KIP2 expression was induced by adding 20 ng/mL Dox for 24 h.
Knockout of p57KIP2. Cas9 was amplified with PCR from the Alt-R S.p. Cas9
Expression Plasmid (IDT) and cloned into pCS-3G to generate pCS-3G-Cas9.
The CAG promoter of CS-CA-MCS was replaced with the human U6 (hU6)
promoter, and the gRNA scaffold sequence was cloned downstream of the
hU6 promoter. The resulting vector was designated as pCS-hU6. A gRNA
target sequence for p57KIP2 (5′-GGC GAC AAG ACG CTC CAT CG-3′), which
was designed and evaluated using CHOPCHOP (37), was cloned between the
hU6 promoter and the gRNA scaffold to generate pCS-hU6-p57KIP2.
Lentivirus-expressing Cas9 and the gRNAwas prepared as described above
and transduced into TSbip cells. Cas9 was transiently expressed by adding
100 ng/mL Dox for 24 h, and single cells were cloned by limiting dilution. During
lentivirus transduction and single-cell cloning, we cultured TS cells on plates
coated with 0.5 μg/mL iMatrix-511 (Nippi) using a modified TS medium
(DMEM/F12 supplemented with 1% KSR [Thermo Fisher Scientific], 0.5%
Penicillin-Streptomycin, 0.15% BSA, 1% ITS-X supplement, 200 μM L-ascorbic
acid, 50 ng/mL EGF, 2 μM CHIR99021, 5 μM A83-01, 0.8 mM VPA, and 2.5 μM
Y27632). This medium ameliorated the toxicity of lentivirus and improved
cloning efficiency. Obtained clones were maintained in the original TS me-
dium and analyzed by flow cytometry and Sanger sequencing. Sequences of
the primers used for vector construction and Sanger sequencing are shown
in Dataset S3.
External Data. The RNA-seq and WGBS data for TSbip (Japanese Genotype-
phenotype Archive [JGA] accession no. JGAS00000000117) and CTbip, EVTbip,
and SynTbip (JGA accession no. JGAS00000000038) were from our previous
studies (14, 15).
Statistical Analyses. Results are presented as means + SDs. The statistical
methods used are described in the figure legends. A P value of less than 0.05
was considered statistically significant. P values less than 0.05 and 0.01 were
marked by 1 and 2 asterisks, respectively. Statistical analysis was performed
using Statcel software (OMS) or R (version 3.3.1).
Other Methods. The procedures for immunostaining, CNV analysis, RNA-seq,
real-time PCR, WGBS, and flow cytometory are provided in SI Appendix.
Data Availability. All sequencing data reported in this paper are available at
JGA (accession no. JGAS00000000207) (38).
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